Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Immune checkpoint inhibitors (ICIs) & Esophageal Squamous Cell Carcinoma (ESCC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Immune checkpoint inhibitors (ICIs) are effective in the treatment of advanced esophageal squamous cell carcinoma (ESCC); however, their efficacy in locally advanced resectable ESCC and the potential predictive biomarkers have limited data.
He et al. 2022 The Oncologist 27: e18-e28

…

References (Sources)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
He et al. 2022 The Oncologist 27: e18-e28

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Immune checkpoint inhibitors (ICIs) & Esophageal Squamous Cell Carcinoma (ESCC)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat